Asymmetry Capital Management, L.P. - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 161 filers reported holding CYTOKINETICS INC in Q2 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Asymmetry Capital Management, L.P. ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q4 2021$10,257,000
+16.5%
225,032
-8.6%
5.44%
+2.9%
Q3 2021$8,804,000
+19.5%
246,336
-27.6%
5.29%
+11.8%
Q3 2020$7,366,000
+51.7%
340,253
+65.1%
4.74%
+27.3%
Q2 2020$4,857,000
+101.7%
206,086
+0.9%
3.72%
+41.3%
Q1 2020$2,408,000
+166.4%
204,251
+139.8%
2.63%
+62.6%
Q4 2019$904,00085,1721.62%
Other shareholders
CYTOKINETICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders